Thanks to a transformational gift from the Midwest Athletes Against Childhood Cancer (MACC) Fund, a talented team of UW doctors is working on revolutionary treatments for pediatric cancer. The concept that inspired this remarkable team is innovative immunotherapy, which focuses on giving children the best chance at living long, healthy lives.
Research supported through the MACC Fund is making a significant impact at the Carbone Cancer Center and American Family Children’s Hospital, helping increase the five-year survival rate for all types of childhood cancers from 20 percent to over 80 percent and providing groundbreaking options for even the most difficult-to-treat childhood cancers.
“The MACC Fund is about more than funding science labs, research, and infrastructure — it’s about taking care of the kids,” explains David Margolis MD’89, pediatric hematology-oncology specialist and program director at Children’s Wisconsin. “The MACC Fund is the cornerstone of the research. It’s an organization that’s enabled us to treat, create investigator initiatives, develop novel treatment, and invest in human capital. We’re playing on a much bigger stage in the medical community, allowing us to write the playbook versus following it.”